Abstract:ConspectusAllostery, or allosteric regulation, is the phenomenon in which protein functional activity is altered by the binding of an effector at an allosteric site that is topographically distinct from the orthosteric, active site. As one of the most direct and efficient ways to regulate protein function, allostery has played a fundamental role in innumerable biological processes of all living organisms, including enzyme catalysis, signal transduction, cell metabolism, and gene transcription. It is thus considered as "the second secret of life". The abnormality of allosteric communication networks between allosteric and orthosteric sites is associated with the pathogenesis of human diseases. Allosteric modulators, by attaching to structurally diverse allosteric sites, offer the potential for differential selectivity and improved safety compared with orthosteric drugs that bind to conserved orthosteric sites. Harnessing allostery has thus been regarded as a novel strategy for drug discovery.Despite much progress having been made in the repertoire of allostery since the turn of the millennium, the identification of allosteric drugs for therapeutic targets and the elucidation of allosteric mechanisms still present substantial challenges. These challenges are derived from the difficulties in the identification of allosteric sites and mutations, the assessment of allosteric protein–modulator interactions, the screening of allosteric modulators, and the elucidation of allosteric mechanisms in biological systems.To address these issues, we have developed a panel of allosteric services for specific allosteric applications over the past decade, including (i) the creation of the Allosteric Database, with the aim of providing comprehensive allosteric information such as allosteric proteins, modulators, sites, pathways, etc., (ii) the construction of the ASBench benchmark of high-quality allosteric sites for the development of computational methods for predicting allosteric sites, (iii) the development of Allosite and AllositePro for the prediction of the location of allosteric sites in proteins, (iv) the development of the Alloscore scoring function for the evaluation of allosteric protein–modulator interactions, (v) the development of Allosterome for evolutionary analysis of query allosteric sites/modulators within the human proteome, (vi) the development of AlloDriver for the prediction of allosteric mutagenesis, and (vii) the development of AlloFinder for the virtual screening of allosteric modulators and the investigation of allosteric mechanisms. Importantly, we have validated computationally predicted allosteric sites, mutations, and modulators in the real cases of sirtuin 6, casein kinase 2α, phosphodiesterase 10A, and signal transduction and activation of transcription 3. Furthermore, our developed allosteric methods have been widely exploited by other users around the world for allosteric research. Therefore, these allosteric services are expected to expedite the discovery of allosteric drugs and the investigation of allosteric mechanisms.

Probing the Activity Modification Space of the Cysteine Peptidase Cathepsin K with Novel Allosteric Modifiers

Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space

Novel selective proline-based peptidomimetics for human cathepsin K inhibition

3D-QSAR and Docking Studies of Aldehyde Inhibitors of Human Cathepsin K.

Improved Method for the Identification and Validation of Allosteric Sites.

Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins

Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis

Integrated machine learning-based virtual screening and biological evaluation for identification of potential inhibitors against cathepsin K

Quinoline‐ and pyrimidine‐based allosteric modulators of the sarco/endoplasmic reticulum calcium ATPase

A Combined approach of QSAR study, molecular docking and pharmacokinetics prediction of promising Amide-Ac6-aminoacetonitriles Cathepsin K inhibitors

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach

Evaluation of Alpha,Beta-Unsaturated Ketone-Based Probes for Papain-Family Cysteine Proteases

Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms

A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods

Real-time analysis of osteoclast resorption and fusion dynamics in response to bone resorption inhibitors

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Allo-targeting of the kinase domain: Insights from in silico studies and comparison with experiments

New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity

Inhibitors of Cathepsins K and S Identified Using the DynaMAD Virtual Screening Algorithm

Cathepsin K: The Action in and Beyond Bone